Skip to content

Humana HUM Additional Paid-In Capital

Additional Paid-In Capital at other companies

Cigna logo
CignaCI
$31.91B+1.5%
Hitachi logo
HitachiHIT
$17.91M+85.2%
Cencora logo
CencoraCOR
$6.3B+2.6%
Centene logo
CenteneCNC
Molina Healthcare logo
Molina HealthcareMOH
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$39.6B+23.5%
Operating income$1.8B-12.9%
Net income$1.2B-4.7%
EPS (diluted)$9.83-4.6%

Balance sheet

See full
Cash & equivalents$5.0B+16.5%
Total debt$14.0B+5.2%
Total equity$18.6B+4.7%
Total assets$55.3B+8.5%

Cash flow

See full
Operating cash flow$1.3B+279%
CapEx$121.0M+27.4%
Free cash flow$1.1B+380%

Valuation

See full
Market cap$47.69B+64.5%
Enterprise value$56.73B+51.1%
P/E15×-1.9×
P/S0.4×+0.1×

Profitability

See full
Operating margin2.7%-1.7pp
Net margin3%-0.1pp
FCF margin4.2%

Returns & leverage

See full
Return on equity18.2%+0.9pp
Debt / equity0.8×0.0×
Current ratio1.8×-0.1×

Where this comes from

Reported directly by Humana in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Humana’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Humana's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Humana's additional paid-in capital?
Humana (HUM) reported additional paid-in capital of $3.64B in Q1 2026.
How has Humana's additional paid-in capital changed year-over-year?
Humana's additional paid-in capital increased by 4.1% year-over-year, from $3.5B to $3.64B.
What is the long-term trend for Humana's additional paid-in capital?
Over 5 years (2020 to 2025), Humana's additional paid-in capital has grown at a 5.9% compound annual growth rate (CAGR), from $2.71B to $3.6B.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.